We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$166M
Cap. Flow
-$17.6M
Cap. Flow %
-0.86%
Top 10 Hldgs %
45.48%
Holding
45
New
3
Increased
11
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$51M
2
NVDA icon
NVIDIA
NVDA
+$43.9M
3
SDRL icon
Seadrill
SDRL
+$10.8M
4
KOS icon
Kosmos Energy
KOS
+$10.1M
5
FBTC icon
Fidelity Wise Origin Bitcoin Fund
FBTC
+$5.38M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.39%
2 Financials 23.2%
3 Communication Services 12.05%
4 Energy 10.1%
5 Healthcare 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$3T
$116M 5.65%
643,989
-78,244
-11% -$13.1M
C icon
2
Citigroup
C
$226B
$112M 5.47%
1,777,075
-112,256
-6% -$6.25M
EXPE icon
3
Expedia Group
EXPE
$37.3B
$101M 4.89%
729,594
-205,896
-22% -$29.3M
OMF icon
4
OneMain Financial
OMF
$7.43B
$95.2M 4.63%
1,863,738
-285,239
-13% -$13.6M
DAL icon
5
Delta Air Lines
DAL
$60B
$91.7M 4.47%
1,916,503
+3,075
+0.2% +$127K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.36T
$90.8M 4.42%
601,537
+949
+0.2% +$136K
ET icon
7
Energy Transfer Partners
ET
$70B
$89.3M 4.35%
5,678,229
+67,312
+1% +$980K
GM icon
8
General Motors
GM
$76.8B
$81.5M 3.97%
1,797,772
-68,595
-4% -$2.66M
META icon
9
Meta Platforms (Facebook)
META
$1.52T
$80.1M 3.9%
164,999
-23,425
-12% -$10.4M
PPLI
10
People Inc
PPLI
$3.2B
$76.7M 3.73%
1,752,082
+85,785
+5% +$3.7M
UBS icon
11
UBS Group
UBS
$176B
$71.9M 3.5%
2,339,900
-111,037
-5% -$3.28M
MAT icon
12
Mattel
MAT
$4.2B
$62.7M 3.05%
3,166,784
-122,287
-4% -$2.32M
CROX icon
13
Crocs
CROX
$6.59B
$60.3M 2.93%
419,057
-2,953
-0.7% -$336K
COIN icon
14
Coinbase
COIN
$40.3B
$57.8M 2.81%
217,836
-14,186
-6% -$2.55M
NVDA icon
15
NVIDIA
NVDA
$5.43T
$54.8M 2.67%
+606,060
New +$43.9M
UAL icon
16
United Airlines
UAL
$41.7B
$53.2M 2.59%
1,110,352
-110,701
-9% -$4.74M
NCLH icon
17
Norwegian Cruise Line
NCLH
$8.83B
$50.5M 2.46%
2,413,260
-120,325
-5% -$2.19M
GOOS
18
Canada Goose Holdings
GOOS
$862M
$49.9M 2.43%
4,133,561
+290,737
+8% +$3.61M
TNL icon
19
Travel + Leisure Co
TNL
$4.69B
$48.4M 2.36%
989,425
-132,862
-12% -$5.67M
KOS icon
20
Kosmos Energy
KOS
$1.52B
$47.9M 2.33%
8,039,144
+1,675,721
+26% +$10.1M
BIIB icon
21
Biogen
BIIB
$30.2B
$47M 2.29%
+217,887
New +$51M
BABA icon
22
Alibaba
BABA
$307B
$45.8M 2.23%
633,201
+56,737
+10% +$4.16M
CVS icon
23
CVS Health
CVS
$122B
$45.7M 2.22%
572,574
-28,403
-5% -$2.17M
SDRL icon
24
Seadrill
SDRL
$2.73B
$45.3M 2.2%
900,306
+237,732
+36% +$10.8M
JPM icon
25
JPMorgan Chase
JPM
$948B
$43.4M 2.11%
216,724
-51,687
-19% -$9.33M

Similar funds

Patient Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Patient Capital Management held 45 positions worth $2.05B, up 8.8% from $1.89B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Patient Capital Management's Q1 2024 filing shows 3 new, 11 increased, 25 reduced and 3 closed positions. Its largest new stake was Biogen: 217,887 shares worth $47M. The largest sale was Expedia Group, an estimated $29.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.

  • Patient Capital Management's largest Q1 2024 buy was Biogen: 217,887 shares worth $47M.
  • Patient Capital Management added most to Seadrill in Q1 2024, an estimated $10.8M increase.
  • Patient Capital Management's biggest Q1 2024 reduction was Expedia Group, cutting an estimated $29.3M.
  • Patient Capital Management fully exited Cleveland-Cliffs in Q1 2024, selling an estimated $21M.
  • Patient Capital Management's ten largest holdings make up 45% of its $2.05B portfolio in Q1 2024.
  • Patient Capital Management opened 3 new positions and closed 3 in Q1 2024.
  • Patient Capital Management's portfolio value rose 8.8% quarter-over-quarter to $2.05B.

Based on Patient Capital Management's 13F filing for Q1 2024, filed 15 May 2024.